3 December, 2024
On November 27, TheMoveMen association celebrated its first anniversary at the Caja Rural de Aragón Auditorium, making a significant donation to the project of the IP Alberto J. Schuhmacher group.
November 7, 2024
Alberto J. Schuhmacher, head of the Molecular Oncology Group at the IIS Aragón, reflects on cancer following the publication of the series of articles by the Nature group, which represent an unprecedented analysis of this disease, turning everything known upside down.
October 3, 2024
On September 27, Alberto Jiménez Schuhmacher, principal investigator of the group, presented "High-precision missiles against tumors", a project that will be funded with the proceeds from the XNUMXth edition of the Monzón Women's Race.
Augusts 20, 2024
The work has been dedicated to Professor María Victoria Arruga, who recently died, and who was the "teacher" of the researcher Alberto J. Schuhmacher. The article was one of the five highlighted among the 157 in the latest issue of the magazine on its website.
30 April 2024
It is one of the results of a study by the Aragon Health Services Research Group (GRISSA) of the IIS Aragón, led by María José Rabanaque, professor of Preventive Medicine and Public Health at the University of Zaragoza.
25 April 2024
El Periódico de Aragón has also selected the profile of Alberto Jiménez Schuhmacher, ARAID researcher and head of the Molecular Oncology Group at IIS Aragón, for its special talent supplement in our Community.
19 March, 2024
Alberto Jiménez Schuhmacher, head of the Molecular Oncology Group of the Aragon Health Research Institute (IIS Aragón) and ARAID researcher, will give a conference this Wednesday at the UNED in Barbastro, at 19:00 p.m.
15 February, 2024
Alberto Jiménez Schuhmacher, ARAID at IIS Aragón, will participate in one of the round tables of the meeting on "Bioinformatics and One-Health".
15 January 2024
Alberto J.Schuhmacher, head of the Molecular Oncology group at IIS Aragón, speaks in Heraldo de Aragón about the need to ventilate in the face of the new increase in respiratory viruses.